Q3 Earnings Estimate for MIRM Issued By Leerink Partnrs
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) – Analysts at Leerink Partnrs issued their Q3 2025 earnings per share (EPS) estimates for Mirum Pharmaceuticals in a report issued on Wednesday, February 26th. Leerink Partnrs analyst M. Foroohar anticipates that the company will post earnings of ($0.25) per share for the quarter. The consensus estimate for […]
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Free Report) – Analysts at Leerink Partnrs issued their Q3 2025 earnings per share (EPS) estimates for Mirum Pharmaceuticals in a report issued on Wednesday, February 26th. Leerink Partnrs analyst M. Foroohar anticipates that the company will post earnings of ($0.25) per share for the quarter. The consensus estimate for […]
